A novel tropomyosin-related kinase A inhibitor, KK5101 to treat pancreatic cancer.
Fang Z, Han B, Jung KH, Lee JH, El-Damasy AK, Gadhe CG, Kim SJ, Yan HH, Park JH, Lee JE, Kang YW, Pae AN, Keum G, Hong SS.
Fang Z, et al. Among authors: lee je, lee jh.
Cancer Lett. 2018 Jul 10;426:25-36. doi: 10.1016/j.canlet.2018.03.041. Epub 2018 Mar 30.
Cancer Lett. 2018.
PMID: 29605512